EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. (12th June 2019) - Dreyling, M.; Santoro, A.; Leppä, S.; Demeter, J.; Follows, G.A.; Lenz, G.; Kim, W.S.; Mollica, L.; Nagler, A.; Phipps Diong, C.; Provencio, M.; Magagnoli, M.; et al.